Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Contract Win

1 May 2024 07:00

RNS Number : 7074M
Renold PLC
01 May 2024
ย 

1 May 2024

ย 

ย 

Renold plc

("Renold", the "Company" or the "Group")

Contract Win

ย 

Renold (AIM: RNO), a leading international supplier of industrial chains and related power transmission products, is pleased to announce that Renold Couplings, part of the Company's Torque Transmission division, has been awarded a contract to manufacture flexible couplings for Batch 1 of the Canadian Surface Combatant ships for the Royal Canadian Navy, worth ยฃ10.6 million. This contract, together with other military work recently awarded, means that Renold's military order book has increased by ยฃ13.1 million, over recent months.

ย 

The contract, to be delivered over the next six years is for flexible couplings, which are an important component of a ship's propulsion system and form part of Renold's Hi-Tec range of couplings, which are supplied worldwide for large marine and industrial projects.

ย 

The Canadian Surface Combatant ships will be built by Irving Shipbuilding Inc in the Halifax Shipyard, Nova Scotia. The contract award represents a significant extension of the Group's collaboration with Canada in supplying flexible couplings for naval vessels. The Canadian Surface Combatant will replace the Halifax class warships which also used Renold Flexible Couplings. Manufacture of the flexible couplings for the Canadian Surface Combatant is anticipated to commence mid-2024 in Renold's Cardiff facility.

ย 

Renold CEO, Robert Purcell, commented:

ย 

"I am delighted that Renold are working with Irving Shipbuilding Inc on the next generation of Canadian warships. The award of the Canadian Surface Combatant contract builds on the success of our naval flexible couplings business which is already working on the British and Australian naval programmes and this success underpins our belief in the Renold Hi-Tec product range.

ย 

"This excellent long-term contract will further reinforce our Couplings business performance and shows the on-going benefits of our product development strategy combined with our manufacturing and engineering excellence."

ย 

ENQUIRIES:

ย 

Renold plcย 

0161 498 4500

Robert Purcell, Chief Executive

ย 

Jim Haughey, Group Finance Director

ย 

ย 

Peel Hunt LLP (Nominated Adviser and Joint Broker)

020 7418 8900

ย 

Mike Bell

ย 

ย 

Ed Allsopp

ย 

ย 

ย 

Cavendish Capital Markets Limited (Joint Broker)

020 7220 0500

ย 

Ed Frisby / Tim Harper (Corporate Finance)

ย 

ย 

Andrew Burdis / Harriet Ward (ECM)

ย 

ย 

ย 

ย 

IFC Advisory Limited (Financial PR and IR)

020 3934 6630

ย 

Tim Metcalfe

renold@investor-focus.co.uk

ย 

Graham Herring

ย 

ย 

ย 

NOTES FOR EDITORS:

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well-deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

ย 

Further information about Renold can be found on the website at:ย www.renold.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
CNTQKKBQKBKBPQN
Date   Source Headline
25th Aug 20217:00 amRNSHolding(s) in Company
23rd Aug 202112:11 pmRNSResult of AGM
23rd Aug 20217:00 amRNSAGM Trading Update
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
29th Jul 20214:41 pmRNSSecond Price Monitoring Extn
29th Jul 20214:36 pmRNSPrice Monitoring Extension
28th Jul 20217:00 amRNSPosting of Annual Report and Notice of AGM
27th Jul 202112:50 pmRNSDirector/PDMR Shareholding
26th Jul 20218:55 amRNSGrant of Options
19th Jul 202111:23 amRNSDirector/PDMR Shareholding
16th Jul 20217:00 amRNSFinal Results
13th Jul 20217:00 amRNSFlexible Coupling Contract Award
8th Jul 20219:47 amRNSNotice of results for the year ended 31 March 2021
23rd Jun 20213:30 pmRNSHolding(s) in Company
18th Jun 20217:00 amRNSBlock listing Six Monthly Return
16th Jun 20217:00 amRNSNotice of results for the year ended 31 March 2021
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSInvestor Presentation – 17 June 2021
28th May 202112:35 pmRNSNotice of Results
27th May 20214:02 pmRNSCapital Reduction
26th May 20218:30 amRNSPreference Stock Dividend
4th May 202110:38 amRNSHolding(s) in Company
15th Apr 20215:27 pmRNSResults of General Meeting
14th Apr 20217:00 amRNSTrading Update for the year ended 31 March 2021
29th Mar 20218:40 amRNSNotice of General Meeting
24th Feb 20215:17 pmRNSHolding(s) in Company
9th Feb 20214:37 pmRNSHolding(s) in Company
5th Feb 202112:26 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSHolding(s) in Company
13th Jan 20217:00 amRNSTrading Update
17th Dec 20207:00 amRNSBlock listing Interim Review
26th Nov 20207:00 amRNSPreference Stock Dividend
23rd Nov 20204:15 pmRNSHolding(s) in Company
20th Nov 20207:00 amRNSAppointment of Non-Executive Director
18th Nov 20204:15 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSGrant of Awards – Performance Share Plan
11th Nov 20207:00 amRNSHalf-year Report
16th Oct 20207:00 amRNSTrading Update
1st Oct 20208:41 amRNSGrant of Awards - Performance Share Plan
24th Sep 20207:00 amRNSRe: Directorate Change
22nd Sep 20203:20 pmRNSDirector/PDMR Shareholding
18th Sep 20203:50 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSPDMR/Directorate Change
24th Jul 20201:23 pmRNSResult of AGM
24th Jul 20207:00 amRNSAGM Statement
26th Jun 20202:57 pmRNSAnnual Report and Accounts
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.